U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
BRIAKINUMAB
978I8M0P8X
Possibly Marketed Outside US
General
Names
14
Classification
3
Identifiers
11
Subunits
4
Related Substances
1
BRIAKINUMAB
978I8M0P8X
Possibly Marketed Outside US
General
Approval Year
Unknown
149,124
Names
14
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
BRIAKINUMAB
Official Name
English
A-796874.0
Preferred Name
English
ABT-874
Code
English
BRIAKINUMAB [USAN]
Common Name
English
BSF 415977
Code
English
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Interleukin inhibitors
ATC
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
Interleukin inhibitors
briakinumab
WHO-ATC
L04AC09
Interleukin inhibitors
VATC
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
Interleukin inhibitors
briakinumab
WHO-VATC
QL04AC09
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
WIKIPEDIA
BRIAKINUMAB
PRIMARY
EVMPD
SUB31454
PRIMARY
SMS_ID
100000124140
PRIMARY
USAN
UU-138
PRIMARY
FDA UNII
978I8M0P8X
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
978I8M0P8X
BRIAKINUMAB